| Name | Title | Contact Details |
|---|
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.
Discoveries to inspire the best life for every child and youth. The CHEO Research Institute is a not for profit corporation that connects exceptional talent and technology in pursuit of life-changing research for every child, youth and family in our community and beyond. We inspire trust in our research excellence by being curious, nimble, passionate and equitable.
Health Interactions is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aya Healthcare creates exceptional experiences – for their clinicians, their corporate employees and the healthcare facilities they serve. For healthcare facilities, Aya delivers a robust suite of software and services to manage the procurement of contingent labor. Aya’s platform provides access to one of the largest sources of contract clinicians in the country which improves efficiency, increases quality and reduces costs for healthcare systems. For travel nurses, Aya delivers the best experience in the industry and allows access to the widest base of travel assignments in the United States.
Johnston Health is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Smithfield, NC. To find more information about Johnston Health, please visit www.johnstonhealth.org